Plain-English translation of NCT06796634 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new device called J-Plasma, which uses cold atmospheric plasma (a type of ionized gas), to treat small tumor nodules during surgery for cancer that has spread to the abdominal lining. Researchers want to see whether applying this plasma treatment to tumors before surgical removal affects how healthy or alive the cancer cells are. This is early-stage research to understand how the treatment works in real patients.
Right now, doctors don't know whether this plasma technology can help treat peritoneal metastases — cancers that have spread throughout the abdominal cavity. This study will help researchers understand whether the treatment can damage or kill cancer tissue, which could eventually lead to better options for patients with this type of advanced cancer.
You likely qualify if…
You likely don't qualify if…
If you qualify and enroll, the plasma treatment would be applied to selected small tumor nodules at the start of your surgery, using different power levels and treatment durations to test effectiveness. After treatment, your surgeon will remove the treated nodules at least 30 minutes later, and these tissue samples will be analyzed in the laboratory to see how the plasma affected the cancer cells. Your main participation happens during your already-planned surgery; no additional hospital visits are required beyond your standard surgical care.
AI-generated summary from trial data · Aug 20, 2026 · Not medical advice
Belgium